HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Narasimhan, M. Articles by Rosen, M. J. Search for Related Content PubMed PubMed Citation Articles by Narasimhan, M. Articles by Rosen, M. J.

Intensive Care in Patients With HIV Infection in the Era of Highly Active Antiretroviral Therapy^*

^* From the Division of Pulmonary and Critical Care Medicine (Drs. Narasimhan, Posner, Mayo, and Rosen), Beth Israel Medical Center, Albert Einstein College of Medicine, New York, NY; and Brown University Medical School (Dr. DePalo), Providence, RI.

Correspondence to: Mark J. Rosen, MD, FCCP, Beth Israel Medical Center, First Ave at 16th St, New York, NY 10003; e-mail: MRosen{at}BethIsraelNY.org

Study objectives: The use of highly active antiretroviral therapy (HAART) has dramatically improved morbidity and mortality in patients with HIV infection. The types of critical illness and their outcomes in HIV-infected patients in recent years is unknown.

Design: We reviewed the medical records of all patients admitted to the Medical ICU of Beth Israel Medical Center, NY, from January to June 2001 and compared their characteristics with patients admitted to the same unit from November 1991 to October 1992.

Results: Of 441 admissions in the first half of 2001, 63 admissions (14%) were in 53 HIV-seropositive patients. There were 65 admissions to the Medical ICU during the 1-year period spanning 1991 to 1992. Compared with the earlier period, the 2001 patients were more likely to be black (52% vs 26%, respectively; p < 0.01) and injection drug users (75% vs 48%, respectively; p < 0.01), and were less likely to be white (11% vs 23%, respectively; difference not significant) and homosexual men (6% vs 26%, respectively; p < 0.01). In 2001, patients were less likely to be admitted with respiratory failure (22% vs 54%, respectively; p < 0.01) and with Pneumocystis jiroveci pneumonia (formerly referred to as Pneumocystis carinii) [3% vs 34%, respectively; p < 0.001], and were more likely to be admitted with non-HIV-related diseases (67% vs 12%, respectively; p < 0.001). Overall survival was much higher in the later period (71% vs 49%, respectively; p < 0.01).

Conclusions: In the era of HAART, more patients with HIV infection were admitted to the ICU over a 12-month period than were 10 years previously. Patients were more likely to be injection drug users and were more likely to be admitted to the ICU because of non-HIV-associated conditions.

Key Words: highly active antiretroviral therapy • HIV • intensive care • outcomes • respiratory failure

This article has been cited by other articles:

				H. Khouli, A. Afrasiabi, M. Shibli, R. Hajal, C. R. Barrett, and P. Homel Outcome of Critically Ill Human Immunodeficiency Virus-Infected Patients in the Era of Highly Active Antiretroviral Therapy J Intensive Care Med, December 1, 2005; 20(6): 279 - 285. [Abstract] [PDF]

				M. J. Rosen Intensive Care of Patients With Human Immunodeficiency Virus Infection: Time to Take Another Look J Intensive Care Med, December 1, 2005; 20(6): 312 - 315. [PDF]

				A. Ahmad, S. Khan, and A. O. Soubani The Findings of Surgical Lung Biopsy in HIV Patients in the Era of Highly Active Antiretroviral Therapy Ann. Thorac. Surg., June 1, 2005; 79(6): 1862 - 1865. [Abstract] [Full Text] [PDF]